TMHC Taylor Morrison Home (TMHC) Insider Trading, Ownership & Congress Trades
Construction · Operative builders · CIK 0001562476
Congress · 1
Insider buyers, 180 days
0
Funds added, last quarter
209
13F, latest reported quarter
Conversions, 180 days
4
Codes C/M, not in net · no price filed
What the filings say about TMHC
Congress, 1 year
1 bought · 1 sold
Latest: sale, 2025-10-31
Taylor Morrison Home insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
No insider purchases or sales are on record for Taylor Morrison Home Corp in the period covered. Source: SEC Form 4 filings, as of 2026-10-28.
Insider
Filed
Shares
Value
Since filing
Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Feb 14, 2022.
- The trade is 2975.0% of the 100 shares held after it.
- No other insider sold within 30 days.
- 209 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Warren Denise sold about $205.9K of TMHC on Feb 13, 2026; 209 funds added in the latest 13F quarter.Context
- 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Feb 14, 2022.
- No other insider sold within 30 days.
- 209 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Warren Denise sold about $6.9K of TMHC on Feb 13, 2026; 209 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- 3 other insiders sold within 30 days.
- 209 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EVP, CLO & Secretary Merrill Stevin Todd sold about $309.0K of TMHC on Sep 12, 2025; 3 other insiders sold within 30 days and 209 funds added in the latest 13F quarter.Context
- First Form 4 purchase or sale (code P or S) here by this insider on our record.
- The trade is 29.1% of the 48,191 shares held after it.
- 3 other insiders sold within 30 days.
- 209 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MARIUCCI ANNE L sold about $980.1K of TMHC on Sep 11, 2025; 3 other insiders sold within 30 days and 209 funds added in the latest 13F quarter.Context
- 19 earlier Form 4 trades (code P or S) here by this insider (19 sales), the last on Aug 22, 2025.
- The trade is 3.6% of the 370,475 shares held after it.
- 3 other insiders sold within 30 days.
- 209 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Chairman, President and CEO Palmer Sheryl sold about $973.7K of TMHC on Sep 5, 2025; 3 other insiders sold within 30 days and 209 funds added in the latest 13F quarter.197 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Seven facts, ranked against the sector ·
Rank is not a forecast
Insiders
no insider buys or sells on file
Congress
1 member bought in the last year
the lowest in Construction
Funds
209 funds bought in last quarter
more than 68% of Construction
Revenue
-0.6% year over year
below 63% of Construction
Margin
9.6% net margin
more than 84% of Construction
Buybacks
$149.6M repurchased, FY to 2026-03-31
more than 67% of Construction
Short interest
no short interest reported
What changed in the last 30 days
Nothing new filed in the last 30 days
Watch TMHC
A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.
Who owns TMHC: institutional holders (13F)
13F holdings, latest reported quarter
13,987,929 sh
$1.0B
6,508,962 sh
$467.0M
4,439,153 sh
$318.5M
4,389,390 sh
$314.9M
4,054,952 sh
$290.9M
Congress trades in TMHC
STOCK Act disclosures, US House only, filed up to 45 days after the trade
Sold 2025-10-31 · disclosed 21 days later
$1,001 - $15,000
Bought 2025-10-30 · disclosed 22 days later
$1,001 - $15,000
Sold 2025-10-30 · disclosed 22 days later
$1,001 - $15,000
Bought 2025-06-17 · disclosed 57 days later
$1,001 - $15,000
Activist and 5% holders (13D/13G)
No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.
TMHC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MERRITT DAVID C
Filed 2026-06-23
$1.3M
TMHC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
First Trust Merger Arbitrage Fund
$184.4M position · as of 2026-06-30
11.3%
Nexpoint Merger Arbitrage Fund
$73.7M position · as of 2026-06-30
4.9%
State Street(R) SPDR(R) S&P(R) Homebuilders ETF
$48.4M position · as of 2026-06-30
3.0%
Muhlenkamp Fund
$6.5M position · as of 2026-06-30
2.5%
iShares U.S. Home Construction ETF
$64.7M position · as of 2026-06-30
2.5%
First Trust Multi-Strategy Fund
$29.8M position · as of 2026-06-30
2.2%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Sheryl D. Palmer
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$15.4M
$23.9M
$4.2M
+180%
+130%
2023
$14.4M
$25.0M
$3.8M
+144%
+109%
2022
$8.8M
$6.9M
$2.3M
+39%
+33%
2021
$12.1M
$17.7M
$3.8M
+60%
+88%
2020
$10.4M
$11.1M
$2.5M
+17%
+27%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 209 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade. Each figure is a federal filing, dated the day it went public.
TMHC financials
Revenue growth
-0.6%
XBRL, annual
Net margin
9.6%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$7.6B
four quarters, 2025-04-01 to 2026-03-31
Revenue, TTM TMHC
| FY Dec 2025 | $8.1B |
| FY Dec 2024 | $8.2B |
| FY Dec 2023 | $7.4B |
| FY Dec 2022 | $8.2B |
| FY Dec 2021 | $7.5B |
| Mar 2026 | $1.4B |
| Dec 2025 | $2.1B |
| Sep 2025 | $2.1B |
| Jun 2025 | $2.0B |
| Mar 2025 | $1.9B |
| Dec 2024 | $2.4B |
| Sep 2024 | $2.1B |
| Jun 2024 | $2.0B |
At each fiscal year end
Single quarter
Net margin, TTM
+8.8%
net income over revenue, 2025-04-01 to 2026-03-31
Net margin, TTM TMHC
| FY Dec 2025 | +9.6% |
| FY Dec 2024 | +10.8% |
| FY Dec 2023 | +10.4% |
| FY Dec 2022 | +12.8% |
| FY Dec 2021 | +8.8% |
| Mar 2026 | +7.1% |
| Dec 2025 | +8.3% |
| Sep 2025 | +9.6% |
| Jun 2025 | +9.5% |
| Mar 2025 | +11.3% |
| Dec 2024 | +10.3% |
| Sep 2024 | +11.8% |
| Jun 2024 | +10.0% |
At each fiscal year end
Single quarter
Free cash flow, TTM
$687.9M
operating cash flow minus capex, 2025-04-01 to 2026-03-31
Free cash flow, TTM TMHC
| FY Dec 2025 | $777.0M |
| FY Dec 2024 | $173.7M |
| FY Dec 2023 | $772.7M |
| FY Dec 2022 | $1.1B |
| FY Dec 2021 | $355.4M |
| Mar 2026 | -$20.4M |
| Dec 2025 | $635.3M |
| Sep 2025 | $206.6M |
| Jun 2025 | -$133.6M |
| Mar 2025 | $68.7M |
| Dec 2024 | $428.2M |
| Sep 2024 | $127.1M |
| Jun 2024 | -$241.7M |
At each fiscal year end
Single quarter
Debt to equity
0.37x
long-term debt only, 2026-03-31; equity 2026-03-31
Debt to equity TMHC
| FY Dec 2025 | 0.36x |
| FY Dec 2024 | 0.36x |
| FY Dec 2023 | 0.38x |
| FY Dec 2022 | 0.54x |
| FY Dec 2021 | 0.84x |
| Mar 2026 | 0.37x |
| Dec 2025 | 0.36x |
| Sep 2025 | 0.35x |
| Jun 2025 | 0.35x |
| Mar 2025 | 0.35x |
| Dec 2024 | 0.36x |
| Sep 2024 | 0.37x |
| Jun 2024 | 0.39x |
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.31x
TTM operating cash flow over long-term debt only, 2026-03-31
Cash flow to debt TMHC
| FY Dec 2025 | 0.36x |
| FY Dec 2024 | 0.10x |
| FY Dec 2023 | 0.40x |
| FY Dec 2022 | 0.45x |
| FY Dec 2021 | 0.11x |
| Mar 2026 | 0.31x |
| Dec 2025 | 0.36x |
| Sep 2025 | 0.28x |
| Jun 2025 | 0.25x |
| Mar 2025 | 0.20x |
| Dec 2024 | 0.10x |
| Sep 2024 | 0.01x |
| Jun 2024 | -0.08x |
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+10.9%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on equity TMHC
| FY Dec 2025 | +12.9% |
| FY Dec 2024 | +15.8% |
| FY Dec 2023 | +15.5% |
| FY Dec 2022 | +24.6% |
| FY Dec 2021 | +17.8% |
| Mar 2026 | +10.9% |
| Dec 2025 | +12.9% |
| Sep 2025 | +14.3% |
| Jun 2025 | +15.5% |
| Mar 2025 | +15.9% |
| Dec 2024 | +15.8% |
| Sep 2024 | +14.9% |
| Jun 2024 | +13.8% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.0%
TTM net income over average of 2025-03-31 and 2026-03-31
Return on assets TMHC
| FY Dec 2025 | +8.2% |
| FY Dec 2024 | +9.8% |
| FY Dec 2023 | +9.0% |
| FY Dec 2022 | +12.2% |
| FY Dec 2021 | +8.1% |
| Mar 2026 | +7.0% |
| Dec 2025 | +8.2% |
| Sep 2025 | +9.0% |
| Jun 2025 | +9.7% |
| Mar 2025 | +9.9% |
| Dec 2024 | +9.8% |
| Sep 2024 | +9.2% |
| Jun 2024 | +8.2% |
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital TMHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed TMHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | n/a |
| FY Dec 2023 | n/a |
| FY Dec 2022 | n/a |
| FY Dec 2021 | n/a |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | n/a |
| Jun 2025 | n/a |
| Mar 2025 | n/a |
| Dec 2024 | n/a |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
10.80x
close 2026-07-23 over four quarters of diluted EPS, 2025-04-01 to 2026-03-31
P/E, trailing TMHC
| FY Dec 2025 | 7.58x |
| FY Dec 2024 | 7.39x |
| FY Dec 2023 | 7.64x |
| FY Dec 2022 | 3.33x |
| FY Dec 2021 | 6.72x |
| Mar 2026 | 8.68x |
| Dec 2025 | 7.58x |
| Sep 2025 | 7.95x |
| Jun 2025 | 7.09x |
| Mar 2025 | 6.98x |
| Dec 2024 | 7.39x |
| Sep 2024 | 9.29x |
| Jun 2024 | 8.24x |
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$8.5B
market value at close 2026-07-23 on 2026-04-22 shares, plus long-term debt only, 2026-03-31, minus cash 2026-03-31
Enterprise value TMHC
| FY Dec 2025 | $7.2B |
| FY Dec 2024 | $8.0B |
| FY Dec 2023 | $7.0B |
| FY Dec 2022 | $5.0B |
| FY Dec 2021 | $6.8B |
| Mar 2026 | $7.3B |
| Dec 2025 | $7.2B |
| Sep 2025 | $8.3B |
| Jun 2025 | $8.1B |
| Mar 2025 | $7.8B |
| Dec 2024 | $8.0B |
| Sep 2024 | $9.2B |
| Jun 2024 | $7.8B |
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+10.2%
TTM free cash flow over market value at close 2026-07-23
FCF yield TMHC
| FY Dec 2025 | +13.5% |
| FY Dec 2024 | +2.7% |
| FY Dec 2023 | +13.5% |
| FY Dec 2022 | +32.8% |
| FY Dec 2021 | +8.3% |
| Mar 2026 | +12.3% |
| Dec 2025 | +13.5% |
| Sep 2025 | +8.7% |
| Jun 2025 | +8.0% |
| Mar 2025 | +6.3% |
| Dec 2024 | +2.7% |
| Sep 2024 | +0.2% |
| Jun 2024 | -3.3% |
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
trailing EPS growth -22%, PEG needs growth
PEG, trailing TMHC
| FY Dec 2025 | n/a |
| FY Dec 2024 | 0.40x |
| FY Dec 2023 | n/a |
| FY Dec 2022 | 0.04x |
| FY Dec 2021 | 0.04x |
| Mar 2026 | n/a |
| Dec 2025 | n/a |
| Sep 2025 | 0.81x |
| Jun 2025 | 0.25x |
| Mar 2025 | 0.30x |
| Dec 2024 | 0.40x |
| Sep 2024 | n/a |
| Jun 2024 | n/a |
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-07-23. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
| 2025-12 | 2024-12 | 2023-12 | 2022-12 | |
|---|---|---|---|---|
| Revenue | $8.1B | $8.2B | $7.4B | $8.2B |
| Gross profit | $1.9B | $2.0B | $1.8B | $2.1B |
| Net income | $782.5M | $883.3M | $768.9M | $1.1B |
| EPS (diluted) | 7.77 | 8.27 | 6.98 | 9.06 |
| Operating cash flow | $817.3M | $210.1M | $806.2M | $1.1B |
| Cash | $850.0M | $487.2M | $798.6M | $724.5M |
| Long-term debt | $2.3B | $2.1B | $2.0B | $2.5B |
| Buybacks | $381.0M | $347.6M | $128.0M | $376.3M |
SEC XBRL, fiscal years, as known on 2026-10-28
TMHC Stock Sonar score 4/7 axes
Find similar shapesCompareTMHC ranks highest on profitability (61st percentile) and financial health (56th), and lowest on growth (37th), among Construction peers.
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
TMHC filings, in plain words
Have members of Congress traded TMHC?
Yes. In the year to 2026-10-28, 1 House member disclosed buying TMHC and 1 House member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31.
Read the full summary
In the year to 2026-10-28, 1 member of Congress disclosed buying TMHC and 1 member disclosed selling it; the latest on record is a sale by Lisa McClain dated 2025-10-31. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
